1. Disparate requirements for RAD54L in replication fork reversal.
- Author
-
Uhrig ME, Sharma N, Maxwell P, Gomez J, Selemenakis P, Mazin AV, and Wiese C
- Subjects
- Humans, Cell Line, Tumor, DNA, Single-Stranded metabolism, DNA, Single-Stranded genetics, BRCA2 Protein genetics, BRCA2 Protein metabolism, BRCA1 Protein metabolism, BRCA1 Protein genetics, Tumor Suppressor p53-Binding Protein 1 metabolism, Tumor Suppressor p53-Binding Protein 1 genetics, DNA Damage Tolerance, Transcription Factors, DNA Replication, DNA Helicases metabolism, DNA Helicases genetics, Rad51 Recombinase metabolism, Rad51 Recombinase genetics, DNA-Binding Proteins metabolism, DNA-Binding Proteins genetics, Nuclear Proteins metabolism, Nuclear Proteins genetics
- Abstract
RAD54L is a DNA motor protein with multiple roles in homologous recombination DNA repair. In vitro, RAD54L was shown to also catalyze the reversal and restoration of model replication forks. In cells, however, little is known about how RAD54L may regulate the dynamics of DNA replication. Here, we show that RAD54L restrains the progression of replication forks and functions as a fork remodeler in human cancer cell lines and non-transformed cells. Analogous to HLTF, SMARCAL1 and FBH1, and consistent with a role in fork reversal, RAD54L decelerates fork progression in response to replication stress and suppresses the formation of replication-associated ssDNA gaps. Interestingly, loss of RAD54L prevents nascent strand DNA degradation in both BRCA1/2- and 53BP1-deficient cells, suggesting that RAD54L functions in both pathways of RAD51-mediated replication fork reversal. In the HLTF/SMARCAL1 pathway, RAD54L is critical, but its ability to catalyze branch migration is dispensable, indicative of its function downstream of HLTF/SMARCAL1. Conversely, in the FBH1 pathway, branch migration activity of RAD54L is essential, and FBH1 engagement is dependent on its concerted action with RAD54L. Collectively, our results reveal disparate requirements for RAD54L in two distinct RAD51-mediated fork reversal pathways, positing its potential as a future therapeutic target., (© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2024
- Full Text
- View/download PDF